Gene therapy studies using HGF have demonstrated beneficial effects in animal models of amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and cerebral ischemia, with HGF treatment promoting neurite extension, increasing synaptogenesis, and enhancing functional recovery
Purpose: To determine if these peptides can be added to the 503A bulk drugs list, allowing compounding pharmacies to create them, reversing earlier restrictions
This is the most common and effective method
SS-31 is an FDA-approved therapeutic, sold under the brand name Forzinity, specifically to treat Barth syndromea rare, severe, and historically fatal genetic mitochondrial disease
Other studies have examined the effect of hexavalent chromium on regulated RBC death
Clin Genitourin Cancer